Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors
出版年份 2016 全文链接
标题
Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors
作者
关键词
-
出版物
Advanced Healthcare Materials
Volume 5, Issue 21, Pages 2788-2798
出版商
Wiley
发表日期
2016-09-08
DOI
10.1002/adhm.201600644
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The hypoxic microenvironment: A determinant of cancer stem cell evolution
- (2016) Amancio Carnero et al. BIOESSAYS
- Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma
- (2016) Hong Yao et al. CANCER LETTERS
- Liquid-based three-dimensional tumor models for cancer research and drug discovery
- (2016) Stephanie L Ham et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
- (2016) Jing Xie et al. MEDICAL ONCOLOGY
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy
- (2016) Dong Geon Kim et al. Oncotarget
- Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia
- (2016) Andrew Dhawan et al. Scientific Reports
- Interfacial Tension Effect on Cell Partition in Aqueous Two-Phase Systems
- (2015) Ehsan Atefi et al. ACS Applied Materials & Interfaces
- Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition
- (2015) Fanying Meng et al. BMC CANCER
- Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer
- (2015) Jessica D Sun et al. CANCER BIOLOGY & THERAPY
- TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
- (2015) S. G. J. A. Peeters et al. CLINICAL CANCER RESEARCH
- Phytochemicals potently inhibit migration of metastatic breast cancer cells
- (2015) Stephanie Lemmo Ham et al. Integrative Biology
- The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast
- (2015) Nilgün Kapucuoğlu et al. PATHOLOGY RESEARCH AND PRACTICE
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Shape, Size, and Aspect Ratio on Nanoparticle Penetration and Distribution inside Solid Tissues Using 3D Spheroid Models
- (2015) Rachit Agarwal et al. Advanced Healthcare Materials
- Bottom-Up Engineering of Well-Defined 3D Microtissues Using Microplatforms and Biomedical Applications
- (2015) Geon Hui Lee et al. Advanced Healthcare Materials
- Three-dimensional in vitro tumor models for cancer research and drug evaluation
- (2014) Xian Xu et al. BIOTECHNOLOGY ADVANCES
- Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
- (2014) Naoki Aomatsu et al. BMC CANCER
- HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma
- (2014) Y J Liu et al. BRITISH JOURNAL OF CANCER
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-cancer Drug Testing in 3D Culture
- (2014) Stephanie Lemmo et al. Cellular and Molecular Bioengineering
- Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events
- (2014) Carolin Bock et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
- (2014) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Ultralow Interfacial Tensions of Aqueous Two-Phase Systems Measured Using Drop Shape
- (2014) Ehsan Atefi et al. LANGMUIR
- Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
- (2014) Danfang Zhang et al. Molecular Cancer
- Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
- (2014) F. W. Hunter et al. MOLECULAR CANCER THERAPEUTICS
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
- (2014) B Muz et al. Blood Cancer Journal
- Aqueous biphasic cancer cell migration assay enables robust, high-throughput screening of anti-cancer compounds
- (2013) Stephanie Lemmo et al. Biotechnology Journal
- Extracellular matrix components in breast cancer progression and metastasis
- (2013) Thordur Oskarsson BREAST
- Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies
- (2013) Valentina Guarneri et al. DRUGS
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Cell to extracellular matrix interactions and their reciprocal nature in cancer
- (2013) Marianne van Dijk et al. EXPERIMENTAL CELL RESEARCH
- CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
- (2013) Suresh Kumar Swaminathan et al. JOURNAL OF CONTROLLED RELEASE
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- CD24 Is an Effector of HIF-1-Driven Primary Tumor Growth and Metastasis
- (2012) S. Thomas et al. CANCER RESEARCH
- New strategies for targeting the hypoxic tumour microenvironment in breast cancer
- (2012) Carol Ward et al. CANCER TREATMENT REVIEWS
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
- (2012) A. Kathleen McClendon et al. CELL CYCLE
- CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
- (2012) Yan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- Three-Dimensional-Engineered Matrix to Study Cancer Stem Cells and Tumorsphere Formation: Effect of Matrix Modulus
- (2012) Xiaoming Yang et al. TISSUE ENGINEERING PART A
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Radiological features of triple-negative breast cancers (73 cases)
- (2012) M. Boisserie-Lacroix et al. Diagnostic and Interventional Imaging
- A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
- (2011) Mohamed A. H. Ahmed et al. BREAST CANCER RESEARCH AND TREATMENT
- HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
- (2011) J. Mathieu et al. CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
- (2011) F. Meng et al. MOLECULAR CANCER THERAPEUTICS
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
- (2011) Zhen Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
- (2011) Abderrahim El Guerrab et al. PLoS One
- Polymeric Aqueous Biphasic Systems for Non-Contact Cell Printing on Cells: Engineering Heterocellular Embryonic Stem Cell Niches
- (2010) Hossein Tavana et al. ADVANCED MATERIALS
- Hypoxia inducible factors in cancer stem cells
- (2010) J M Heddleston et al. BRITISH JOURNAL OF CANCER
- Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
- (2010) Christina H. Stuelten et al. STEM CELLS
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
- (2009) E Y Tan et al. BRITISH JOURNAL OF CANCER
- Nanolitre liquid patterning in aqueous environments for spatially defined reagent delivery to mammalian cells
- (2009) H. Tavana et al. NATURE MATERIALS
- The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas
- (2008) Eleni Mylona et al. HUMAN PATHOLOGY
- Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
- (2008) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search